Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply. | N Engl J Med;389(4): 378-379, 2023 Jul 27. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply.

Tuttle, Jay; Emery, Paul; Nirula, Ajay.

Affiliation

Tuttle J; Eli Lilly, San Diego, CA.
Emery P; University of Leeds, Leeds, United Kingdom.
Nirula A; Eli Lilly, San Diego, CA nirula_ajay@lilly.com.

N Engl J Med ; 389(4): 378-379, 2023 Jul 27.

Article in En | MEDLINE | ID: mdl-37494493

Subject(s)

Arthritis, Rheumatoid; Humans; Adult; Arthritis, Rheumatoid/drug therapy; Severity of Illness Index

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid Limits: Adult / Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article Affiliation country: Canada

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid Limits: Adult / Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article Affiliation country: Canada